Mesenchymal stromal cell secretory molecules improve the functional survival of human islets.
Tzu-Wen HongSara CaxariaLydia F Daniels GatwardSufyan HussainMin ZhaoAileen J F KingChloe L RackhamPeter M JonesPublished in: Diabetic medicine : a journal of the British Diabetic Association (2023)
Pre-treating human islets before transplantation with a defined cocktail of MSC-derived molecules could be employed to improve the quality of human islets for transplantation therapy for type 1 diabetes.